|
⚲
|
| Keyboard |
| Steve Gullans | |
|---|---|
| Firm | |
| Address | 800 Boylston Street Suite 2825 Boston, MA 02199 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Gemphire Therapeutics Inc | 021-283723 | Director | 12.5 M of 12.5 M |
||
| Gemphire Therapeutics Inc | 021-245322 | Director | 10.6 M of 14.0 M |
||
| Cleveland Heartlab Inc | 021-220585 | Director | 2.8 M | ||
| Nanomr Inc | 021-208520 | Director | 2.4 M of 2.4 M |
||
| Pathogenetix Inc | 021-204537 | Director | 3.6 M of 9.1 M |
||
| Nanomr Inc | 021-199233 | Director | 2.6 M of 2.6 M |
||
| Cleveland Heartlab Inc | 021-186326 | Director | 14.7 M of 14.7 M |
||
| Cleveland Heartlab Inc | 021-165590 | Director | 18.3 M of 18.3 M |
||
| Tetraphase Pharmaceuticals Inc | 021-142724 | Director | 44.8 M of 45.0 M |
||